FDA — authorised 26 February 2004
- Application: BLA125085
- Marketing authorisation holder: GENENTECH
- Status: supplemented
FDA authorised Avastin on 26 February 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 26 February 2004; FDA has authorised it.
GENENTECH holds the US marketing authorisation.